Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
about
Whole-Body Vibration as a Modality for the Rehabilitation of Peripheral Neuropathies: Implications for Cancer Survivors Suffering from Chemotherapy-Induced Peripheral NeuropathyAmerican Cancer Society Colorectal Cancer Survivorship Care GuidelinesNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewLifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review.Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like ChemotherapyA phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsNorth Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyChemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancerA double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives.Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP studyNatural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study.Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture.Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Mechanosensitivity in the upper extremity following breast cancer treatment.A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignanciesEvaluation of Cisplatin Neurotoxicity in Cultured Rat Dorsal Root Ganglia via Cytosolic Calcium Accumulation.Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial.Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidenceAcupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
P2860
Q26771423-4C612DA2-CCCA-43E2-A4D5-DE821F0DA70CQ26782671-D9C2184E-EF9F-45C6-AE5E-7D98AC09308DQ28270819-5A32CE5D-6E51-4F6D-A64D-239532500CCCQ30234847-DA4E72AD-8FCB-4AC6-B3D7-2725FBE68FD4Q33688318-09DC6630-2866-43B6-9AB9-3B5F4C80DB04Q33693343-A5BF1A5A-636B-41A5-B815-D83C4D155B6AQ33717608-2AE50949-329D-4F3D-9A99-043FBB3A33DCQ33889319-29244121-B84F-4837-A561-07368639174CQ34095827-3DAE16AF-4B02-4812-847C-8E627FB03E2EQ34380579-BA708621-50F3-443A-98EE-7483911CAB9CQ34418413-F7A47EA6-4668-4338-BB0C-732E991FD2BEQ34619839-9F1572E0-7E9E-48EB-882F-0886A6F37831Q35898601-F4E7B196-7B04-4771-AA1B-B6643F2367E2Q35898610-5F679A91-6426-4D8A-9B17-4DFB73B1F336Q36336106-D22D495C-3347-4EE5-A548-C5450FA558DAQ36893328-A0E55263-47BE-42D7-8CF6-50303928BB61Q37143510-DF533300-ED15-466F-9CC8-F33DFD4621B8Q37166705-BA31D924-5B5A-4795-B716-3C5DC7C599DBQ37398949-068D0343-3282-4B1A-B5D1-C3BFEFF0E71DQ37399781-1DE44734-97BD-4CB9-AF44-56D2519EBF95Q37519464-29A3F07C-D44C-400C-9668-D375210C2CA2Q37582203-401FA5A0-AF71-4894-843E-DCA52ACA1764Q38426849-A17FA0B9-7795-4192-95DF-4C98FD36F178Q41475920-42B37EC0-3320-4231-BA5F-E3FFF12F7E5EQ41894069-08005427-FEE2-4ABF-AE45-08DEC49155BBQ42565168-5127E0DA-AB81-4A23-BAC5-65365E48F3ECQ46235962-E585AA20-193C-4E68-AE1D-6D4BD6FA6957Q47805054-9C3FDFEB-28A4-4EE1-87B9-404CD359A48FQ58698934-14EEB393-66F9-4C24-B886-7D05A806CE1AQ58699231-62E86809-D34E-49B5-A0A3-F851208A369B
P2860
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@ast
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@en
type
label
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@ast
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@en
prefLabel
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@ast
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@en
P1476
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
@en
P2093
Allyson J Ocean
Linda T Vahdat
P2888
P304
P356
10.1007/S00520-004-0657-7
P577
2004-09-01T00:00:00Z